Sign in
4

Changes in Ownership

Fulgent Genetics, Inc. Filed Acc 0001209191-21-054292

Director sold 936 shares at an average $91.29 ($85,449)

  • Director acquired 936 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BOLGER JOHN C · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-30 Exercise or conversion : show line 1 in the form +312 $3.93 $1,225 2,312 D
2021-08-30 Sale : show line 2 in the form −312 $91.38 $28,511 2,000 D
2021-08-30 Exercise or conversion : show line 3 in the form +312 $15.82 $4,936 2,312 D
2021-08-30 Sale : show line 4 in the form −312 $91.05 $28,409 2,000 D
2021-08-30 Exercise or conversion : show line 5 in the form +312 $5.81 $1,813 2,312 D
2021-08-30 Sale : show line 6 in the form −312 $91.44 $28,530 2,000 D
Open-market sales · 936 sh · avg $91.29 · $85,449

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-08-30 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −312 938 D
2021-08-30 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −312 2,188 D
2021-08-30 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −312 3,438 D
Loading xslF345X03/doc4.xml…